Kyle Kline - 01 Dec 2025 Form 4/A - Amendment Insider Report for GLOBUS MEDICAL INC (GMED)

Role: Senior Vice President, CFO
Signature: /s/ Kelly G. Huller, Attorney-in-Fact
Issuer symbol: GMED
Transactions as of: 01 Dec 2025
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 13 Jan 2026, 17:40:58 UTC
Date Of Original Report: 03 Dec 2025
Previous filing: 27 Aug 2025
Next filing: 12 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kline Kyle	Senior Vice President, CFO	VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE, AUDUBON	/s/ Kelly G. Huller, Attorney-in-Fact	13 Jan 2026	0002080625

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GMED	Stock Option (Right to Buy Class A Common Stock)	Options Exercise	$0	-4,896	-98%	$0.000000	104	01 Dec 2025	Class A Common Stock	4,896	$63.68	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 3, 2025, the reporting person filed a Form 4 which inadvertently reported in Table II that 5,000 options were exercised prior to the sale of the underlying 4,896 shares of the issuer's Class A Common Stock that was reported in Table I. As correctly reported in this amendment, the reporting person exercised 4,896 options prior to the sale of the underlying 4,896 shares of the issuer's Class A Common Stock.
F2	These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Content

On December 3, 2025, the reporting person filed a Form 4 which inadvertently reported in Table II that 5,000 options were exercised prior to the sale of the underlying 4,896 shares of the issuer's Class A Common Stock that was reported in Table I. As correctly reported in this amendment, the reporting person exercised 4,896 options prior to the sale of the underlying 4,896 shares of the issuer's Class A Common Stock.

These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.